Subscribe to RSS

DOI: 10.1055/s-0045-1809972
Recurrent Pandoraea pnomenusa Catheter-Related Bloodstream Infections in an Immunosuppressed Child: A Case Report with Review of Literature
Authors
Funding None.

Abstract
The list of emerging pathogens is continuously expanding. Pandoraea pnomenusa is an emerging multidrug-resistant gram-negative bacterium reported in immunocompromised patients. This case report describes an 8-year-old pediatric patient with metastatic extrarenal rhabdoid tumor who developed recurrent catheter-related bloodstream infections (CRBSI) following the placement of a peripherally inserted central catheter (PICC). One month after PICC insertion, the child developed CRBSI. Blood cultures identified a gram-negative organism, which was subsequently identified as P. pnomenusa using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Initial antibiotic therapy resulted in transient improvement, but a second episode of CRBSI occurred with persistent positive cultures. The child was treated with a prolonged course of antibiotics and required PICC removal. Imipenem, tetracyclines, and co-trimoxazole are the preferred antibiotics for treating this pathogen. The awareness of P. pnomenusa as a rare but important cause of catheter-related infection is crucial for prompt identification and initiation of appropriate and effective antimicrobial therapy.
Patient's Consent
The authors confirm that all necessary patient consent forms have been obtained. The patient has provided written permission for their medical images and clinical details to be included in this publication. They have been informed that their identity will be protected by withholding their name and initials.
Publication History
Article published online:
03 July 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Pimentel JD, MacLeod C. Misidentification of Pandoraea sputorum isolated from sputum of a patient with cystic fibrosis and review of Pandoraea species infections in transplant patients. J Clin Microbiol 2008; 46 (09) 3165-3168
- 2 Singh S, Sahu C, Patel SS, Garg A, Ghoshal U. Pandoraea apista bacteremia in a COVID-positive man: a rare coinfection case report from North India. J Lab Physicians 2021; 13 (02) 192-194
- 3 Coenye T, Falsen E, Hoste B. et al. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol 2000; 50 (Pt 2): 887-899
- 4 Ambrose M, Malley RC, Warren SJ. et al. Pandoraea pnomenusa isolated from an Australian patient with cystic fibrosis. Front Microbiol 2016; 7: 692
- 5 Cubides-Diaz DA, Muñoz Angulo N, Martin Arsanios DA, Ovalle Monroy AL, Perdomo-Rodriguez DR, Del-Portillo MP. Pandoraea pnomenusa superinfection in a patient with SARS-CoV-2 pneumonia: first case in the literature. Infect Dis Rep 2022; 14 (02) 205-212
- 6 Falces-Romero I, Gutiérrez-Arroyo A, Romero-Gómez MP. [Catheter-associated bacteremia by Pandoraea pnomenusa in an infant with acute lymphoblastic leukemia]. Med Clin (Barc) 2016; 147 (03) 132
- 7 Daneshvar MI, Hollis DG, Steigerwalt AG. et al. Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies. J Clin Microbiol 2001; 39 (05) 1819-1826
- 8 Schneider I, Queenan AM, Bauernfeind A. Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa. Antimicrob Agents Chemother 2006; 50 (04) 1330-1335
- 9 Bodendoerfer E, Personnic N, Mestres CA, Wilhelm MJ, Meyer L, Hasse B. Possible prosthetic valve endocarditis by Pandoraea pnomenusa and specific virulence mechanisms. Infect Drug Resist 2021; 14: 1319-1324